Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


04.02.2019

1 Antiviral Res
2 Cell
1 J Exp Med
1 J Immunol
1 J Infect Dis
3 J Virol
1 MMWR Morb Mortal Wkly Rep
2 PLoS Comput Biol
2 PLoS One
3 Vaccine
4 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antiviral Res

  1. WATANABE A, Ishida T, Hirotsu N, Kawaguchi K, et al
    Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study.
    Antiviral Res. 2019;163:75-81.
    PubMed     Text format     Abstract available


    Cell

  2. VAHEY MD, Fletcher DA
    Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.
    Cell. 2019;176:678.
    PubMed     Text format    

  3. GAO GF
    From "A"IV to "Z"IKV: Attacks from Emerging and Re-emerging Pathogens.
    Cell. 2018;172:1157-1159.
    PubMed     Text format     Abstract available


    J Exp Med

  4. KOSIK I, Angeletti D, Gibbs JS, Angel M, et al
    Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies.
    J Exp Med. 2019 Jan 25. pii: jem.20181624. doi: 10.1084/jem.20181624.
    PubMed     Text format     Abstract available


    J Immunol

  5. BLUNDELL PA, Lu D, Wilkinson M, Dell A, et al
    Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers with Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus.
    J Immunol. 2019 Jan 25. pii: jimmunol.1801337. doi: 10.4049/jimmunol.1801337.
    PubMed     Text format     Abstract available


    J Infect Dis

  6. PRASAD N, Huang QS, Wood T, Aminisani N, et al
    Influenza associated outcomes among pregnant, post-partum, and non-pregnant women of reproductive age.
    J Infect Dis. 2019 Jan 23. pii: 5299596. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  7. SOUDANI N, Hage-Sleiman R, Karam W, Dbaibo G, et al
    Ceramide suppresses influenza A virus replication in vitro.
    J Virol. 2019 Jan 30. pii: JVI.00053-19. doi: 10.1128/JVI.00053.
    PubMed     Text format     Abstract available

  8. LINSTER M, Schrauwen EJA, van der Vliet S, Burke DF, et al
    The molecular basis for antigenic drift of human A/H2N2 influenza viruses.
    J Virol. 2019 Jan 30. pii: JVI.01907-18. doi: 10.1128/JVI.01907.
    PubMed     Text format     Abstract available

  9. CHRISTENSEN SR, Toulmin SA, Griesman T, Lamerato LE, et al
    Assessing the protective potential of H1N1 influenza virus hemagglutinin head and stalk antibodies in humans.
    J Virol. 2019 Jan 30. pii: JVI.02134-18. doi: 10.1128/JVI.02134.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  10. WASHINGTON EJ, Rose EB, Langley GE, Hand JP, et al
    Notes from the Field: Respiratory Syncytial Virus Infections in a Neonatal Intensive Care Unit - Louisiana, December 2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:20-21.
    PubMed     Text format    


    PLoS Comput Biol

  11. CHAKRABORTY P, Lewis B, Eubank S, Brownstein JS, et al
    What to know before forecasting the flu.
    PLoS Comput Biol. 2018;14:e1005964.
    PubMed     Text format    

  12. MAJARIAN TD, Murphy RF, Lakdawala SS
    Learning the sequence of influenza A genome assembly during viral replication using point process models and fluorescence in situ hybridization.
    PLoS Comput Biol. 2019;15:e1006199.
    PubMed     Text format     Abstract available


    PLoS One

  13. YUN JW, Choi MJ, Shin GS, Lim JO, et al
    Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea.
    PLoS One. 2019;14:e0209643.
    PubMed     Text format     Abstract available

  14. CHAKHUNASHVILI G, Wagner AL, Power LE, Janusz CB, et al
    Severe Acute Respiratory Infection (SARI) sentinel surveillance in the country of Georgia, 2015-2017.
    PLoS One. 2018;13:e0201497.
    PubMed     Text format     Abstract available


    Vaccine

  15. LU J, Luo M, Yee AZH, Sheldenkar A, et al
    Do superstitious beliefs affect influenza vaccine uptake through shaping health beliefs?
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30071.
    PubMed     Text format     Abstract available

  16. SAHIN Z, Neeleman R, Haines J, Kayser V, et al
    Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30050.
    PubMed     Text format     Abstract available

  17. GHORBANI A, Ngunjiri JM, Xia M, Elaish M, et al
    Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30100.
    PubMed     Text format     Abstract available


    Virology

  18. ZOU S, Zhang Y, Li X, Bo H, et al
    Molecular characterization and receptor binding specificity of H9N2 avian influenza viruses based on poultry-related environmental surveillance in China between 2013 and 2016.
    Virology. 2019;529:135-143.
    PubMed     Text format     Abstract available

  19. LEE YT, Kim KH, Ko EJ, Kim MC, et al
    Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
    Virology. 2019;529:111-121.
    PubMed     Text format     Abstract available

  20. SANADA T, Yasui F, Honda T, Kayesh MEH, et al
    Avian H5N1 influenza virus infection causes severe pneumonia in the Northern tree shrew (Tupaia belangeri).
    Virology. 2019;529:101-110.
    PubMed     Text format     Abstract available

  21. NIKOLAIDIS M, Mimouli K, Kyriakopoulou Z, Tsimpidis M, et al
    Large-scale genomic analysis reveals recurrent patterns of intertypic recombination in human enteroviruses.
    Virology. 2019;526:72-80.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: